Author

Xuesong Liu

The First Affiliated Hospital, Sun Yat-sen UniversityPrimary ORCID profile (0000-0002-7736-0077 · 11 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Xuesong LiuiD11 papers · ShanghaiTech University

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:proteomics· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1

Frequent Co-Authors

Chen ZhengiD· 1 shared Fan BaiiD· 1 shared Feizhe Xiao· 1 shared Feng LuoiD· 1 shared Jian ZhongiD· 1 shared Jiying Cheng· 1 shared Junju Chen· 1 shared Lanjie CheniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Chen ZhengORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Glioblastoma Hijacks Astrocyte Ribosomes to Feul Malignancy through Translatome Reprogramming

Xujia Wu, Chen Zheng, Lanjie Chen, Junju Chen, Yuchao Zhang, Long Cheng, Yushan Peng, Xuechao Zeng, Mingpu Gao, Feng Luo, Yanxing Lai, Jiying Cheng, Yixin Gao, Jian Zhong, Xuesong Yang, , Nu Zhang

This study shows glioblastoma hijacks astrocyte ribosomes via tunneling nanotubes, reprograms the tumor translatome to promote malignancy, and identifies INTS12 as a therapeutic target.

bioRxiv · Oct 29, 2026 · PreprintCancer Biology